Venus Remedies rose 11.21% to Rs 158.70 at 10:31 IST on BSE after the company said its board will meet on 30 June 2015 to consider preferential allotment of shares/warrants to promoters.
The announcement was made after market hours yesterday, 22 June 2015.
Meanwhile, the BSE Sensex was up 123.68 points, or 0.45%, to 27,853.89.
On BSE, so far 2.47 lakh shares were traded in the counter, compared with an average volume of 1.40 lakh shares in the past one quarter.
The stock hit a high of Rs 162 and a low of Rs 148.80 so far during the day. The stock hit a 52-week high of Rs 381.75 on 15 September 2014. The stock hit a 52-week low of Rs 96.10 on 23 March 2015.
The stock had underperformed the market over the past one month till 22 June 2015, sliding 12.56% compared with 0.81% fall in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 37.74% as against Sensex's 1.88% fall.
Also Read
The small-cap company has an equity capital of Rs 11.44 crore. Face value per share is Rs 10.
Venus Remedies said its board will meet on 30 June 2015, to consider issuing fully convertible warrants/equity shares to promoters on a preferential basis, subject to approval in the general meeting.
The board will also fix the date of annual general meeting.
Venus Remedies reported net loss of Rs 20.66 crore in Q4 March 2015 as against net profit of Rs 14.11 crore in Q4 March 2014. Net sales declined 28.33% to Rs 98.39 crore in Q4 March 2015 over Q4 March 2014.
Venus Remedies is a fully integrated pharmaceutical company.
Powered by Capital Market - Live News